Author:
Teraoka Shunsuke,Fujimoto Daichi,Morimoto Takeshi,Kawachi Hayato,Ito Munehiro,Sato Yuki,Nagata Kazuma,Nakagawa Atsushi,Otsuka Kojiro,Uehara Keiichiro,Imai Yukihiro,Ishida Kaori,Fukuoka Junya,Tomii Keisuke
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference25 articles.
1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015
2. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin Proc,2008
3. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015
4. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015
5. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016
Cited by
318 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献